Hedgehog- and mTOR-targeted therapies for advanced basal cell carcinomas

Vismodegib for the treatment of basal cell skin cancer

(2013) L. Poggi et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Basal cell carcinoma: a paradigm for targeted therapies

(2013) Jil Dreier et al.   EXPERT OPINION ON PHARMACOTHERAPY

Vismodegib: The first drug approved for advanced and metastatic basal cell carcinoma

(2013) AK Dubey et al.   Journal of Postgraduate Medicine

Indian Hedgehog Controls Proliferation and Differentiation in Skin Tumorigenesis and Protects against Malignant Progression

(2013) Parisa Kakanj et al.   Cell Reports

Initial Assessment of Tumor Regrowth After Vismodegib in Advanced Basal Cell Carcinoma

(2012) Anne Lynn S. Chang et al.   ARCHIVES OF DERMATOLOGY

Inhibiting the Hedgehog Pathway in Patients with the Basal-Cell Nevus Syndrome

(2012) Jean Y. Tang et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma

(2012) Aleksandar Sekulic et al.   NEW ENGLAND JOURNAL OF MEDICINE

Emerging Treatments and Signaling Pathway Inhibitors

(2011) Jean Y. Tang et al.   SEMINARS IN CUTANEOUS MEDICINE AND SURGERY

Itraconazole, a Commonly Used Antifungal that Inhibits Hedgehog Pathway Activity and Cancer Growth

(2010) James Kim et al.   CANCER CELL